Literature DB >> 22173852

The effect of add-on treatment with quetiapine on measures of depression, aggression, irritability and suicidal tendencies in children and adolescents.

Josip Podobnik, Iris Foller Podobnik, Neda Grgic, Darko Marcinko, Nela Pivac.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22173852     DOI： 10.1007/s00213-011-2607-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  7 in total

1.  The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).

Authors:  Drew H Barzman; Melissa P DelBello; Caleb M Adler; Kevin E Stanford; Stephen M Strakowski
Journal:  J Child Adolesc Psychopharmacol       Date:  2006-12       Impact factor: 2.576

Review 2.  Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.

Authors:  Alessandro Zuddas; Roberta Zanni; Tatiana Usala
Journal:  Eur Neuropsychopharmacol       Date:  2011-05-06       Impact factor: 4.600

Review 3.  Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice.

Authors:  M De Hert; M Dobbelaere; E M Sheridan; D Cohen; C U Correll
Journal:  Eur Psychiatry       Date:  2011-02-03       Impact factor: 5.361

4.  A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.

Authors:  Melissa P DelBello; Kiki Chang; Jeffrey A Welge; Caleb M Adler; Manasi Rana; Meghan Howe; Holly Bryan; Daniel Vogel; Suzanne Sampang; Sergio V Delgado; Michael Sorter; Stephen M Strakowski
Journal:  Bipolar Disord       Date:  2009-08       Impact factor: 6.744

5.  Quetiapine in patients with borderline personality disorder: an open-label trial.

Authors:  Ann Romine; Eric Brown; Paul Thuras; Susanne Lee; S Charles Schulz
Journal:  Ann Clin Psychiatry       Date:  2008 Oct-Dec       Impact factor: 1.567

Review 6.  Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?

Authors:  P Francis Abraham; Joseph R Calabrese
Journal:  J Affect Disord       Date:  2008-03-04       Impact factor: 4.839

7.  A 26-week open-label study of quetiapine in children with conduct disorder.

Authors:  Robert L Findling; Michael D Reed; Mary Ann O'Riordan; Christine A Demeter; Robert J Stansbrey; Nora K McNamara
Journal:  J Child Adolesc Psychopharmacol       Date:  2007-02       Impact factor: 2.576
  7 in total
  3 in total

Review 1.  Use of quetiapine in children and adolescents.

Authors:  Gabriele Masi; Annarita Milone; Stefania Veltri; Raffaella Iuliano; Chiara Pfanner; Simone Pisano
Journal:  Paediatr Drugs       Date:  2015-04       Impact factor: 3.022

2.  Prescribing Practices of Quetiapine for Insomnia at a Tertiary Care Inpatient Child and Adolescent Psychiatry Unit: A Continuous Quality Improvement Project.

Authors:  Elaine Stephanie Chow; Azadeh Zangeneh-Kazemi; Olabode Akintan; Elizabeth Chow-Tung; Alan Eppel; Khrista Boylan
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2017-07-01

Review 3.  Interventions for self-harm in children and adolescents.

Authors:  Keith Hawton; Katrina G Witt; Tatiana L Taylor Salisbury; Ella Arensman; David Gunnell; Ellen Townsend; Kees van Heeringen; Philip Hazell
Journal:  Cochrane Database Syst Rev       Date:  2015-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.